Gaurav Mohit Chattree, MD
Neurology · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 17
- 3 carriers
- Office
- 1
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
17 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Chattree’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
17 of 17 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A157024 · Current
Licensed to practise in California · since 2018 · expires 2028-07-31 · University of Texas Southwestern Medical School at Dallas.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$20,295
Medicare paid this office $20,295 for 102 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 38 | $4,149 | $75 |
| New patient visit (60+ min) | 25 | $3,584 | $143 |
| Long return visit (40+ min) | 25 | $3,382 | $125 |
| Return visit (30+ min) | 16 | $2,368 | $108 |
| New patient visit (45+ min) | 21 | $2,251 | $107 |
See all 6 services
| Return visit (30+ min) | 38 | $4,149 | $75 |
| New patient visit (60+ min) | 25 | $3,584 | $143 |
| Long return visit (40+ min) | 25 | $3,382 | $125 |
| Return visit (30+ min) | 16 | $2,368 | $108 |
| New patient visit (45+ min) | 21 | $2,251 | $107 |
| Short return visit (20+ min) | 16 | $1,187 | $59 |
Who their Medicare patients are
102 Original Medicare patients in 2024. Average age 74 · Women 53% · Also on Medicaid 22% · Health risk score 1.54. At or below the middle of the specialty; the typical neurology clinician is at 1.61.
Conditions among them: High blood pressure 60% · Depression 37% · Dementia 25% · Coronary heart disease 24% · Diabetes 20% · Cancer 19% · Chronic kidney disease 18% · Atrial fibrillation 17% · Stroke 12%.
The office billed $66,878, Medicare allowed $28,217 and paid $20,295; for 219 services of 18 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 102 | 219 | 74 | 1.54 | $66,878 | $20,295 |
| 2023 | 74 | 183 | 74 | 1.90 | $65,833 | $15,051 |
| 2022 | 52 | 101 | 74 | 1.42 | $36,444 | $8,342 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 3 services
| Return visit (30+ min) | 34 | $5,207 | $84 |
| Long return visit (40+ min) | 18 | $2,729 | $130 |
| Short return visit (20+ min) | 16 | $954 | $56 |
2022: 2 services
| Return visit (30+ min) | 28 | $3,026 | $86 |
| Muscle electrical test | 16 | $292 | $18 |
Drugs they prescribed that Part D paid
$126,283
Pharmacies billed $126,283 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
434 generic and 76 brand-name prescriptions · $126,283 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Rytary | Parkinson's | 32 | $58,055 | $1,814 |
| Carbidopa | None | 17 | $6,212 | $365 |
| Carbidopa-Levodopa | None | 117 | $5,956 | $51 |
| Rasagiline Mesylate | None | 17 | $3,639 | $214 |
| Carbidopa-Levodopa Er | None | 41 | $3,336 | $81 |
See all 11 drugs
| Rytary | Parkinson's | 32 | $58,055 | $1,814 |
| Carbidopa | None | 17 | $6,212 | $365 |
| Carbidopa-Levodopa | None | 117 | $5,956 | $51 |
| Rasagiline Mesylate | None | 17 | $3,639 | $214 |
| Carbidopa-Levodopa Er | None | 41 | $3,336 | $81 |
| Rivastigmine | None | 11 | $3,055 | $278 |
| Rivastigmine | None | 32 | $2,131 | $67 |
| Amantadine | None | 27 | $746 | $28 |
| Gabapentin | None | 14 | $407 | $29 |
| Clonazepam | None | 29 | $344 | $12 |
| Baclofen | None | 12 | $219 | $18 |
Year by year
| 2024 | 510 | 82 | None | 15% | $126,283 |
| 2023 | 452 | 88 | None | 18% | $144,222 |
| 2022 | 341 | 102 | None | 13% | $105,784 |
| 2021 | 164 | 60 | None | 9% | $24,150 |
| 2020 | 56 | 22 | 0% (0) | None | $6,486 |
| 2019 | 20 | 11 | 0% (0) | None | $2,178 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 7 drugs
| Rytary | Parkinson's | 47 | $71,074 | $1,512 |
| Carbidopa-Levodopa | None | 116 | $8,803 | $76 |
| Carbidopa-Levodopa Er | None | 53 | $3,591 | $68 |
| Rivastigmine | None | 33 | $2,442 | $74 |
| Duloxetine | None | 19 | $1,880 | $99 |
| Clonazepam | None | 31 | $632 | $20 |
| Donepezil | None | 11 | $164 | $15 |
2022: 10 drugs
| Rytary | Parkinson's | 18 | $29,165 | $1,620 |
| Carbidopa | None | 15 | $9,491 | $633 |
| Carbidopa-Levodopa Er | None | 38 | $2,372 | $62 |
| Quetiapine | None | 12 | $1,787 | $149 |
| Rivastigmine | None | 15 | $1,680 | $112 |
| Carbidopa-Levodopa | None | 52 | $1,662 | $32 |
| Mirtazapine | None | 14 | $649 | $46 |
| Gabapentin | None | 17 | $195 | $11 |
| Clonazepam | None | 26 | $139 | $5 |
| Donepezil | None | 16 | $131 | $8 |
2021: 4 drugs
| Carbidopa-Levodopa Er | 13 | $682 | $52 |
| Carbidopa-Levodopa | 14 | $640 | $46 |
| Gabapentin | 23 | $247 | $11 |
| Sulfamethoxazole-Trimethoprim | 12 | $25 | $2 |
Money from drug and device companies
$46 in 2025
| 2025 | 1 | 2 | None | $46 |
| 2024 | 1 | 1 | $1,100 | $1,100 |
| 2023 | 1 | 1 | None | $139 |
| 2022 | 1 | 1 | None | $149 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Medtronic | Percept PC Brainsense | $46 | 2 payments
|
See all 2 published payments
| Medtronic | Meals · 2025-03-25 | Percept PC Brainsense | $22 |
| Medtronic | Meals · 2025-03-19 | Percept PC Brainsense | $24 |
See earlier years (2024, 2023, 2022)
2024: $1,100
| Medtronic | Percept PC Brainsense | $1,100 | 1 payment
|
2023: $139
| Medtronic | Percept PC Brainsense | $139 | 1 payment
|
2022: $149
| Insightec | Exablate | $149 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1427581818
- Licence
- CA A157024California A157024: Current · expires 2028-07-31
- Trained
- University of Texas Southwestern Medical School at Dallas, 2017
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Neurology (2084N0400X)
- Mailing address
- File 57326, Los Angeles, CA, 90074
- NPI first listed
- 2017-04-04
- NPI last updated
- 2026-08-14
- NPI record certified
- 2026-08-14
This is when the NPI record was last certified, not a medical board exam.